Lipocalin 2 is protective against E. coli pneumonia

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Wu, Hong ^a   Santoni Rugiu, Eric ^a   Ralfkiaer, Elisabeth ^a   Porse, Bo T ^b   Moser, Claus ^a   Høiby, Niels ^a   Borregaard, Niels ^a   Cowland, Jack B ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FERRICHROME; GELATINASE B; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIDEROPHORE; ACUTE PHASE PROTEIN; LCN2 PROTEIN, MOUSE; LIPOCALIN; MMP9 PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BONE MARROW CELL; BRONCHUS MUCOSA; CELL MIGRATION; CONTROLLED STUDY; ESCHERICHIA COLI PNEUMONIA; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; MORTALITY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; WESTERN BLOTTING; WILD TYPE; ANIMAL; BACTERIAL PNEUMONIA; C57BL MOUSE; DISEASE MODEL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; LUNG; LUNG ALVEOLUS CELL; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; RESPIRATORY TRACT MUCOSA; TIME;

ACUTE-PHASE PROTEINS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FERRICHROME; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; LIPOCALINS; LUNG; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ONCOGENE PROTEINS; PNEUMOCYTES; PNEUMONIA, BACTERIAL; RESPIRATORY MUCOSA; SIDEROPHORES; TIME FACTORS;

EID: 77956701446     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-96     Document Type: Article

References (27)

1. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009, 22(2):240-73. Table, 10.1128/CMR.00046-08, 2668232, 19366914.
2. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003, 170(11):5583-5589.
3. Borregaard N, Sorensen OE, Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007, 28(8):340-345. 10.1016/j.it.2007.06.002, 17627888.
4. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994, 83(3):799-807.
5. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997, 45(1):17-23. 10.1006/geno.1997.4896, 9339356.
6. Friedl A, Stoesz SP, Buckley P, Gould MN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 1999, 31(7):433-441. 10.1023/A:1003708808934, 10475571.
7. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996, 38(3):414-420. 10.1136/gut.38.3.414, 1383072, 8675096.
8. Cowland JB, Sorensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003, 171(12):6630-6639.
9. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996, 318(Pt 1):1-14. 1217580, 8761444.
10. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002, 10(5):1033-1043. 10.1016/S1097-2765(02)00708-6, 12453412.
11. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432(7019):917-921. 10.1038/nature03104, 15531878.
12. Johansen HK, Hoiby N. Rat model of chronic Pseudomonas aeruginosa lung infection. Handbook of animal models of infection 1999, 517-526. London: Academic Press, Zak O, Sande MA.
13. Johansen HK, Hougen HP, Cryz SJ, Rygaard J, Hoiby N. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats. Am J Respir Crit Care Med 1995, 152(4 Pt 1):1337-1346.
14. Klausen P, Niemann CU, Cowland JB, Krabbe K, Borregaard N. On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur J Haematol 2005, 75(4):332-340. 10.1111/j.1600-0609.2005.00511.x, 16146540.
15. Harjai K, Chhibber S, Bhau LN, Sharma S. Introduction of plasmid carrying an incomplete set of genes for aerobactin production alters virulence of Escherichia coli HB101. Microb Pathog 1994, 17(4):261-270. 10.1006/mpat.1994.1071, 7715424.
16. Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure (Camb) 2005, 13(1):29-41.
17. Braun V. Iron uptake by Escherichia coli. Front Biosci 2003, 8:s1409-s1421. 10.2741/1232, 12957834.
18. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006, 103(6):1834-1839. 10.1073/pnas.0510847103, 1413671, 16446425.
19. Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P, Kolls JK. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 2009, 182(8):4947-4956. 10.4049/jimmunol.0803282, 2708928, 19342674.
20. Iwamura C, Nakayama T. Toll-like receptors in the respiratory system: their roles in inflammation. Curr Allergy Asthma Rep 2008, 8(1):7-13. 10.1007/s11882-008-0003-0, 18377768.
21. Bachman MA, Miller VL, Weiser JN. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog 2009, 5(10):e1000622. 10.1371/journal.ppat.1000622, 2757716, 19834550.
22. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, Aderem A, Smith KD. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 2006, 103(44):16502-16507. 10.1073/pnas.0604636103, 1637611, 17060628.
23. Nelson AL, Barasch JM, Bunte RM, Weiser JN. Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol 2005, 7(10):1404-1417. 10.1111/j.1462-5822.2005.00566.x, 16153241.
24. Valdez JM, Scheinberg P, Young NS, Walsh TJ. Infections in patients with aplastic anemia. Semin Hematol 2009, 46(3):269-276. 10.1053/j.seminhematol.2009.03.008, 19549579.
25. Lagamayo EN. Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries. Am J Infect Control 2008, 36(4 Suppl):S101-S108. 10.1016/j.ajic.2007.10.020, 18468549.
26. Weber MA, Klein NJ, Hartley JC, Lock PE, Malone M, Sebire NJ. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet 2008, 371(9627):1848-1853. 10.1016/S0140-6736(08)60798-9, 18514728.
27. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365(9466):1231-1238. 10.1016/S0140-6736(05)74811-X, 15811456.